Filtered By:
Therapy: Dialysis
This page shows you your search results in order of date. This is page number 2.
Order by Relevance | Date
Total 1186 results found since Jan 2013.
Risk factors and prognosis for coronavirus disease 2019 among 131 hemodialysis patients during the Omicron variant epidemic
In conclusion, COVID-19 was prevalent among patients undergoing MHD, even during the Omicron variant epidemic. Age, nutritional status, comorbidities, and inflammatory factors were associated with disease severity and prognosis.PMID:37501590 | PMC:PMC10388811 | DOI:10.1080/0886022X.2023.2228924
Source: Renal Failure - July 28, 2023 Category: Urology & Nephrology Authors: Wen Wen Shiming Cai Yuehong Li Xianglan Wu Source Type: research
Anti-SARS-CoV-2 IgG antibody titer after BNT162b2 mRNA COVID-19 vaccination in Japanese patients who underwent renal replacement therapy, hemodialysis, peritoneal dialysis, and kidney transplantation
ConclusionsRRT patients, particularly KT recipients, exhibited poor vaccine responses. Booster vaccination would be beneficial for HD and PD patients; however, its effect in KT recipients was mild. Further COVID-19 vaccinations using the latest vaccine or alternative procedures should be considered in RRT patients.
Source: Clinical and Experimental Nephrology - July 26, 2023 Category: Urology & Nephrology Source Type: research
Outcome of COVID-19 and tolerance of Remdesivir in patients with renal failure: a single center experience from Pakistan
Conclusions: COVID-19 in renal failure has a high risk for ICU admissions leading to increased mortality. Multiple comorbidities and raised inflammatory markers are predictors of poor outcomes. We observed no significant drug-related adverse effects, and none of our patients required discontinuation of RDV due to worsening renal function.
Source: The Journal of Infection in Developing Countries - June 29, 2023 Category: Infectious Diseases Authors: Zaheer Udin Babar, Sunil Kumar Dodani, Asma Nasim, Jawahar Lal Langhani, Sanjay Kumar Badlani Source Type: research
Clinical efficacy of the fourth dose of the BNT162b2 vaccine in maintenance dialysis patients
CONCLUSIONS: As seen in the general population and with previous vaccine boosters, the fourth dose of the BNT162b2 vaccine reduced rates of severe COVID-19-related hospitalization and mortality among chronic dialysis patients. Further studies are needed to establish the optimal regimens of vaccination for patients on chronic dialysis.PMID:37326951 | DOI:10.1007/s40620-023-01667-z
Source: Journal of Nephrology - June 16, 2023 Category: Urology & Nephrology Authors: Keren Cohen-Hagai Tzipi Hornik-Lurie Sydney Benchetrit Naomi Nacasch Ayelet Grupper Yael Einbinder Ori Wand Moshe Shashar Source Type: research
Lessons from SENCOVAC: A prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum
Nefrologia (Engl Ed). 2023 May 5:S2013-2514(23)00074-3. doi: 10.1016/j.nefroe.2023.04.005. Online ahead of print.ABSTRACTSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has negatively impacted on patients of the whole CKD spectrum, causing high rates of morbi-mortality. SARS-CoV-2 vaccines opened a new era, but patients with CKD (including kidney transplant, hemodialysis and peritoneal dialysis) were systematically excluded from pivotal clinical trials. The Spanish Society of Nephrology promoted the multicentric national SENCOVAC study aimed at assessing immunological responses after vaccination in patients wi...
Source: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia - May 7, 2023 Category: Urology & Nephrology Authors: Borja Quiroga Mar ía José Soler Alberto Ortiz Patricia de Sequera SENCOVAC collaborative network Source Type: research
Effect of Lymphocyte Phenotypic Alterations on the Humoral Response to Vaccination Against SARS-COV-2 in Dialysis Patients
CONCLUSIONS: Age, diabetes, and hemodialysis prescription had significant impacts on the response to vaccination. T- and B-lymphocyte phenotypes are major determinants of the humoral response potency to SARS-CoV-2 vaccination with BNT162b2 in patients with ESRD.PMID:37080746 | DOI:10.3343/alm.2023.43.5.451
Source: Annals of Laboratory Medicine - April 24, 2023 Category: Laboratory Medicine Authors: Georgios Lioulios Asimina Fylaktou Despina Asouchidou Aliki Xochelli Vasiliki Nikolaidou Stamatia Stai Michalis Christodoulou Panagiotis Giamalis Ioannis Tsouchnikas Aikaterini Papagianni Maria Stangou Source Type: research
